nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Announcement
|
|
|
1997 |
26 |
2 |
p. 157- 1 p. |
artikel |
2 |
Cardiovascular risk factors during sequentially combined 17β oestradiol and dydrogesterone (Femoston®); results from a one-year study in postmenopausal women
|
Gelfand, M. |
|
1997 |
26 |
2 |
p. 125-132 8 p. |
artikel |
3 |
Change of serum amyloid P component concentrations in women
|
Katou, M. |
|
1997 |
26 |
2 |
p. 153- 1 p. |
artikel |
4 |
Comparison of the local tolerability and adhesion of a new matrix system (Menorest®) for estradiol delivery with an established transdermal membrane system (Estraderm TTS®)
|
Erianne, John A. |
|
1997 |
26 |
2 |
p. 95-101 7 p. |
artikel |
5 |
Confirmation of early menopause in fragile X carriers
|
Partington, M.W. |
|
1997 |
26 |
2 |
p. 152- 1 p. |
artikel |
6 |
Current estrogen-progestin and estrogen replacement therapy in elderly women: association with carotid atherosclerosis
|
Jonas, H.A. |
|
1997 |
26 |
2 |
p. 153-154 2 p. |
artikel |
7 |
Difference of LH and FSH secretory characteristics and degree of concordance between postmenopausal and aging women
|
Genazzani, Alessandro D. |
|
1997 |
26 |
2 |
p. 133-138 6 p. |
artikel |
8 |
Effects of hormone replacement therapy on serum amyloid P component in postmenopausal women
|
Hashimoto, Shigeru |
|
1997 |
26 |
2 |
p. 113-119 7 p. |
artikel |
9 |
Hormonal support of lacrimal function, primary lacrimal deficiency, autoimmunity, and peripheral tolerance in the lacrimal gland
|
Mircheff, A.K. |
|
1997 |
26 |
2 |
p. 155-156 2 p. |
artikel |
10 |
HRT and exercise: effects on bone density, muscle strength and lipid metabolism. A placebo controlled 2-year prospective trial on two estrogen-progestin regimens in healthy postmenopausal women
|
Heikkinen, Jorma |
|
1997 |
26 |
2 |
p. 139-149 11 p. |
artikel |
11 |
Impact of a 12-month exercise program on the physical and psychological health of osteopenic women
|
Bravo, G. |
|
1997 |
26 |
2 |
p. 151-152 2 p. |
artikel |
12 |
Low bone mass and fast rate of bone loss at menopause: equal risk factors for future fracture. A 15-year follow-up study
|
Riis, B.J. |
|
1997 |
26 |
2 |
p. 154-155 2 p. |
artikel |
13 |
Menopause — a modern perspective from a controversial history
|
Utian, Wulf H. |
|
1997 |
26 |
2 |
p. 73-82 10 p. |
artikel |
14 |
Mortality following fractures in older women: the study of osteoporotic fractures
|
Browner, W.S. |
|
1997 |
26 |
2 |
p. 152- 1 p. |
artikel |
15 |
Postmenopausal estrogen and progestin use and the risk of cardiovascular disease
|
Grodstein, F. |
|
1997 |
26 |
2 |
p. 153- 1 p. |
artikel |
16 |
Risk factors for osteoporotic fractures in elderly men
|
Nguyen, T.V. |
|
1997 |
26 |
2 |
p. 154- 1 p. |
artikel |
17 |
Sexuality, hormones and the menopausal transition
|
Dennerstein, Loraine |
|
1997 |
26 |
2 |
p. 83-93 11 p. |
artikel |
18 |
The confirmation of a biochemical marker for women's hormonal migraine: the depo-estradiol challenge test
|
Lichten, E.M. |
|
1997 |
26 |
2 |
p. 151- 1 p. |
artikel |
19 |
The effect of hormone replacement therapy on vitamin E status in postmenopausal women
|
Wen, Yichuan |
|
1997 |
26 |
2 |
p. 121-124 4 p. |
artikel |
20 |
Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints versus estradiol-releasing vaginal ring with a vaginal progesterone suppository: clinical and endometrial responses
|
Antoniou, G. |
|
1997 |
26 |
2 |
p. 103-111 9 p. |
artikel |
21 |
Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross-sectional study
|
Walsh, L.J. |
|
1997 |
26 |
2 |
p. 155- 1 p. |
artikel |